US Pharma MarketingA boom in GLP-1s and health care costs, AI-designed hair growth drugs, and more biotech news from The Readout Eli Lilly Obesity Donald Trump Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out A decade of reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Newsletter The Readout The China debate gets louder in Washington A boom in GLP-1s and…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hi from BIO! I’m sitting in the frigid media room here next to STAT’s Brittany Trang, who is writing something scintillating about artificial intelligence.
Today, we’ve got Lilly chasing aesthetics with a AI-designed experimental hair loss drug from Absci, see a stark rise in the U.S. health care spending, and consider China’s ever-rising presence in biopharma.
Source: STAT News Pharma